Elsa Science has contributed to multiple research projects over the years and we continue to engage in a wide array of research initiatives as part of our commitment to science and advancing the rheumatic healthcare system. We are dedicated to democratize science, develop safe and meaningful products and generate convincing evidence to fuel value-based healthcare in rheumatology.Explore projectsExplore publications
SPIDeRR aims to disentangle the real-life complexity of early diagnosis of rheumatic diseases by considering the complete web of factors influencing patients’ symptoms. SPIDeRR’s approach will go well beyond the state-of-the-art in the following ways:
An explorative observational study with the purpose of investigating the value of “Rheumatic Care” management system for patients with Rheumatoid Arthritis by investigating disease activity, quality of life, patient satisfaction as well as healthcare utilization.
A European project aiming to change care of rheumatic diseases, from current long-term expensive treatment towards prevention, to earlier diagnosis and early curative care.
RealHOPE is a European research project that aims to measure and simulate real-life events during the handling of sensitive protein drugs. The goal is to support a safe and efficient use of these drugs for patients through practical recommendations and education, to ensure careful handling of drugs throughout the whole chain – healthcare, pharmacy staff and patients.
The purpose of this project is to 1) develop a prognosis feature based on clinical data and integrate into a self-care app for people with Rheumatoid Arthritis and 2) evaluate the effect of the usage of the self-care app in a prospective randomized clinical trial. Recruitment ongoing.
A project focused on personalized medicine in Rheumatoid Arthritis, aiming to improve the prediction of therapy outcome by combining genomics, biomarkers, clinical- and patient-derived data from the Nordic countries. Research study ongoing.
Jennifer Viberg Johansson, Hanna Blyckert, Karin Schölin Bywall; BMJ Open, 2023
Aim: to explore the experiences of individuals with RA interacting with healthcare. The study also looked at how a self-care application, an educational programme called the ‘healthcare encounter’, improved patient–doctor communication.Read more
K Lundberg, L Qin, C Aulin et al.; RMD Open, 2023
Aim: Examine usability and acceptance of the digital symptom-checker “Rheumatic?” in a real-world setting.Read more
K Schölin Bywall, J Viberg Johansson, I Erlandsson et al.; BMJOpen, 2022
Aim: Explore patient perspectives on patient-centredness in precision medicine for Rheumatoid Arthritis treatment.Read more
Rachel Knevel, Johannes Knitza, Aase Hensvold, Alexandra Circiumaru, Tor Bruce, Sebastian Evans, Tjardo Maarseveen, Marc Maurits, Liesbeth Beaart-van de Voorde, David Simon, Arnd Kleyer, Martina Johannesson, Georg Schett, Tom Huizinga, Sofia Svanteson, Alexandra Lindfors, Lars Klareskog, Anca Catrina; Front. Med., 2022
Aim: Test “Rheumatic?” in individuals suspecting a rheumatic disease to analyze its discriminatory ability between patients with and without immune-mediated rheumatic diseases.Read more
K Schölin Bywall, B Appel Espensen, M Lason et al.; Clin Rheumatol, 2022
Aim: Identify patient-relevant treatment attributes to consider when individualizing treatment for patients with Rheumatoid ArthritisRead more
Develop a prognosisfeature based on clinical data and integrate into a self-care app for people with RA. Evaluate the effect of the usage of the self-care app in a clinical study.Read more
A European project aiming to change care of rheumatic diseases, from current long-term expensive treatment towards prevention, earlier diagnosis and early curative care.Read more
Vivamus sagittis lacus vel augue laoreet rutrum faucibus dolor auctor. Nulla vitae elit libero, a pharetra augue.Read more
Morbi leo risus, porta ac consectetur ac, vestibulum at eros. Curabitur blandit tempus porttitor.Read more
Fusce dapibus, tellus ac cursus commodo, tortor mauris condimentum nibh, ut fermentum massa justo sit amet risus. Nullam id dolor id nibh ultricies vehicula ut id elit. Nulla vitae elit libero, a pharetra augue.Read more